- About the PharmD
- Admissions
- Admissions Overview
- Policies and Disclosures
- Financial Aid and Cost
- Application Process
- Application Process Overview
- Step 1: Minimum Eligibility Requirements
- Step 2: The Application
- Step 3: Interview Process
- Step 4: After Applying
- Frequently Asked Questions and Tips
- Applying Without U.S. Citizenship or Permanent Resident Status
- PharmD-PhD
- Post-Baccalaureate Program
- Pharm Tech to PharmD Pathway Program
- Student Life
- Curriculum
- Connect
- Info for...
News
Serena Huntington, PharmD ’11, DABAT
Tue Feb 18, 2025
As managing director of the California Poison Control System (CPCS) Fresno/Madera division, Serena Huntington, PharmD ’11, DABAT, has dedicated her career to advancing public health by protecting against toxic exposures in her local community.
Mon Nov 2, 2009
Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S. Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy. Craik will be the...
Fri Oct 16, 2009
UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer surgeon...
Fri Oct 16, 2009
Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective. These...
Thu Oct 15, 2009
Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.
According to the National Cancer Institute (NCI), "To advance the NCI's mission of bringing novel therapies to patients, and to fully exploit...
Wed Oct 14, 2009
UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by producing a visible black pigment. The result is...
Wed Sep 30, 2009
UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady, MD, MPH, on an Institute of Medicine (IOM) committee that in spring 2009 published its findings on conflict of interest in medical research, education, and...
Fri Sep 18, 2009
Mitra Assemi, PharmD, UCSF School of Pharmacy associate professor of clinical pharmacy, has been named the School's assistant dean of accreditation and quality, effective September 1, 2009.
"Mitra has the perfect qualifications for this pivotal position. She understands the complexities of the PharmD program and its...
Tue Sep 8, 2009
Donald Kishi, PharmD, UCSF School of Pharmacy health sciences clinical professor of pharmacy, has been named the School's associate dean of student and curricular affairs by Dean Mary Anne Koda-Kimble, PharmD. The appointment was effective September 1, 2009.
As associate dean, Kishi is responsible for...
Thu Sep 3, 2009
UCSF researchers have identified the two key circuits, compared to hundreds as previously thought, that control a cell's ability to adapt to changes in its environment. These circuits are key to a cell's ability to reset itself after responding to a stimulus. Since disruption of the circuitry can lead to diseases such as diabetes and autoimmune...